Back to search

Aivivo Ltd

10694447

active
Private Limited Company
england wales
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Going concern doubt noted in accounts (-10)

Details

25 BIOINNOVATION CENTRE, CAMBRIDGE, CB4 0FW
Incorporated 28/03/2017

Compliance

Last accounts

31/03/2025

total exemption full

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 27/03/2026

Due 10/04/2027

On track

Industry

72110
Research and experimental development on biotechnology
74909
Other professional, scientific and technical activities

Officers

Dr Peyman Gifani

director · Since 28/03/2017

DIRECTOR

BRITISH · ENGLAND · Age 45

Mr Matthew Gregory Richard Cleevely

director · Since 10/10/2019

DIRECTOR

BRITISH · ENGLAND · Age 42

Also on 3 other boards

Dr Mehdi Shahidi

director · Since 29/10/2019

DIRECTOR (NED)

BRITISH · ENGLAND · Age 60

Persons with Significant Control

Dr Peyman Gifani

75–100% shares
75–100% votes
Appoint directors

British · England · Age 45

25, Bioinnovation Centre, Cambridge, CB4 0FW

Notified 28/03/2017

CompanyRankvs 2238+ SIC 72110 peers
29

Financial strength3th percentile among SIC peers · 1/25
Employees77th percentile among SIC peers · 12/15
LiquidityCurrent ratio 0.41× · 2/20
Longevity9 years trading (max 15) · 9/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10
Show leaderboard
1Werfen Limited
90
2Biopharma Process Systems Limited
90
3Theradex (Europe) Limited
90
4Spicer Consulting Limited
90
5Exmoor Pharma Concepts Limited
90
6Ubc Late Stage (Uk) Limited
90
7Wuxi Apptec Uk Ltd
90
8Bio - Diagnostics Limited
89
9Biointeractions Limited
89
10Ams Advanced Medical Services Limited
89
2238Aivivo Ltd
39
How is this score calculated?
Financial strength1/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees12/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity9/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

Act 2006. The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £. 2.2. Going Concern Disclosure The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going

Key FinancialsYear ending 31/03/2025

Net Worth

-£1.2M

Balance sheet strength

Cash

£647k

Cash in the bank

Net Current Assets

-£1.2M

Working capital

Current Assets

£860k

Current Liabilities

£2.1M

Fixed Assets

£8k

Debtors

£213k

3avg. employees+1

Tax at Year End(2023)

Corp tax-£47k

Director Loans

Directors owe company£10k

Balance Sheet

Intangible assets£2k
Assets less current liabilities-£1.2M
Signed by Dr Peyman Gifani 29 October 2025Prepared with Acorah Software Products - Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.41-£529k
20240.46-£327k
20230.70-£268k
20220.55-£271k
20216.90-£235k
202020.04+£407k
20190.66—

Derived from filed accounts. Not audited figures.